Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study - Wikidata - awgldk - TriplyDB

Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study

Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study

http://www.wikidata.org/entity/Q36181331

about

PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism Total osteocalcin in serum predicts testosterone level in male type 2 diabetes mellitus The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years Effect of weight loss on serum osteocalcin and its association with serum adipokines Osteocalcin Is Not Associated with the Risk of Type 2 Diabetes: Findings from the EPIC-NL Study.New insights into the biology of osteocalcin.Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults Changes in Serum Osteocalcin are Not Associated with Changes in Glucose or Insulin for Osteoporotic Patients Treated with Bisphosphonate.Bone as an endocrine organ relevant to diabetes.Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials.The cross-talk between the skeleton and energy metabolism.Osteocalcin is not a strong determinant of serum testosterone and sperm count in men from infertile couples.Significant inverse association between serum osteocalcin and incident type 2 diabetes in a middle-aged cohort.Regulation of Glucose Handling by the Skeleton: Insights From Mouse and Human Studies.

P2860

Q31161423-3A1D2608-D6B7-408B-8063-60099BA8E997 Q33756367-754B61C0-68E2-493A-A0C3-B9F55CFC950E Q33869676-831F4046-A823-418A-9A5B-F11C501207A2 Q35133159-9DF6496B-6CBC-4398-994E-2630BB25D770 Q35791548-05F02963-4D37-47FE-AF98-4B4035CAFA16 Q36349628-8D295BAE-4FA9-4F04-983B-675E3DBE2D72 Q36982011-6D444415-C75B-49E6-ACBA-3423704D461E Q37191758-A6A9F882-4E4E-41C8-8666-C07CD3822168 Q38262674-ED0DD9F4-974A-4461-947A-7AF0F2CA8D20 Q39176937-4FFC0E2B-73B4-4608-AD66-A602092F7B2D Q43461322-CFDB0845-699E-4181-B5CD-3D1381627865 Q43779806-2A6F10E1-8661-4739-BC1F-C151DA7522A4 Q50972340-F0165B79-367E-493A-970F-25A2DBD4C289 Q51276751-EB36987D-A184-4A68-B41C-C40EC6920AA0 Q53634487-D08F39BF-33FD-4494-9511-A58C92BEDFEE

P2860

Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study

http://www.wikidata.org/entity/Q36181331

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Circulating osteocalcin level ...... retrospective follow-up study

@ast

Circulating osteocalcin level ...... retrospective follow-up study

@en

type

label

Circulating osteocalcin level ...... retrospective follow-up study

@ast

Circulating osteocalcin level ...... retrospective follow-up study

@en

prefLabel

Circulating osteocalcin level ...... retrospective follow-up study

@ast

Circulating osteocalcin level ...... retrospective follow-up study

@en

P1433

Q36181331-E9BF7F59-2B80-42E9-8B0C-8852ABAF0331

P1476

Q36181331-E44FEB35-C547-421D-AA20-7259762BF508

P2093

Q36181331-061F2841-AFF6-4FD7-9839-C3B668B694D4

Q36181331-221C5973-9B79-40EE-8FA8-B4489C1AAF45

Q36181331-24FEF927-C498-48A3-87B4-A73FC05CD6AC

Q36181331-3C344F4B-BBA1-40DE-92DA-DE16A227D955

Q36181331-6EAACFB5-6C87-4532-B9E3-6E188D9A2B69

P2860

Q36181331-008F9BE6-0EE0-46B4-8A53-0300E8B41853

Q36181331-0463168D-1A68-4ED1-8118-F5EE26754769

Q36181331-103799A9-24F9-496B-9429-34430D4B56A0

Q36181331-1FE9CD8D-26DD-4FB4-A54F-20315BDAED4D

Q36181331-22C6F8AB-C52B-4937-BF78-04C1000109D9

Q36181331-25D94A56-D5D3-4A0E-90C6-3DDB1E89B4AD

Q36181331-2612FB25-A9B9-48E1-8982-5A8A0DBDC137

Q36181331-280241D6-D99D-49C4-8A3D-19D6B56F9EA0

Q36181331-326F7594-90E1-4A46-8814-AF7A960DB56A

Q36181331-3E2F462D-E479-4433-A652-0C395AC5C40E

P304

Q36181331-EBFC68F1-74F3-47A4-B4C4-F4D023411C82

P31

Q36181331-DC0AE696-78D8-47B2-ADB4-6ECEC55F2929

P356

Q36181331-99485AFC-FA8F-43ED-A481-D5D4A39FC751

P407

Q36181331-B3E0B5EE-148B-480C-953C-F5A7E1DFDFF0

P433

Q36181331-E13881E3-0C49-463C-ACD9-3E88E30C7294

P478

Q36181331-30DE8B84-4B75-4254-B71C-42E514DC496F

P50

Q36181331-83DA026F-2E5C-4512-B064-856B4DF1D23A

P577

Q36181331-A570DF00-0045-48F2-B400-08B879BA3BA1

P5875

Q36181331-8724C2A5-5AFD-43FD-A92F-9FCA6708A5A9

P698

Q36181331-78204CD3-DAA7-4567-A513-28668ABDEDF1

P921

Q36181331-9D51EA47-0E35-4E45-8983-E895ABA09E60

P932

Q36181331-E930CDAA-1070-4B8C-8107-F834E7B62FDF

P356

P1433

P1476

Circulating osteocalcin level ...... retrospective follow-up study

@en

P2093

Ho Yeon Chung

http://www.w3.org/2001/XMLSchema#string

Jae-Hwan Jee

http://www.w3.org/2001/XMLSchema#string

Kyu Jeung Ahn

http://www.w3.org/2001/XMLSchema#string

Moon-Kyu Lee

http://www.w3.org/2001/XMLSchema#string

You-Cheol Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Endocrine regulation of energy metabolism by the skeleton

Association between serum osteocalcin and markers of metabolic phenotype

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects

Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level.

P304

1919-1924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-2471

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228447031

http://www.w3.org/2001/XMLSchema#string

P698

22773701

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3424992

http://www.w3.org/2001/XMLSchema#string